US hedge fund tidies up Malin investment
Pentwater Capital’s overall interest up from 27.6 per cent so far this year to 28.6 per cent
Pentwater Capital’s overall interest up from 27.6 per cent so far this year to 28.6 per cent
Irish biopharmaceutical company stake part of package sold to Rosetta Capital
Market Beat: Life sciences company is finally delivering, six years after IPO
Irish life-sciences company invested $80m in Oxford-based company in July 2015
Markets report: Aryzta, BoI and PTSB fall but Malin bucks the trend on ISEQ to add 4.8%
Pentwater bought shares at 60% discount to Malin’s ‘intrinsic value’
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices